Corealis Pharma will be attending BIO-Europe 2026, taking place November 9–11 in Cologne, Germany. As Europe's largest and longest-running biopharma partnering conference, BIO-Europe brings together biotechnology companies, pharmaceutical organizations, investors, and industry service providers from more than 60 countries to explore strategic partnerships, licensing opportunities, and drug development collaborations.

David Leroux-Petersen will be attending on behalf of Corealis and looks forward to meeting with biotech and pharmaceutical innovators seeking experienced development and manufacturing partners for oral solid dose programs. BIO-Europe provides a unique platform for connecting with companies advancing novel therapies and exploring opportunities to accelerate development through strategic collaboration.

Whether you're evaluating formulation strategies, planning clinical manufacturing activities, or seeking a trusted partner to support your path from molecule to clinic, Corealis offers the scientific expertise and integrated capabilities to help move your program forward with confidence.

If you'll be attending BIO-Europe 2026, connect with David to discuss your development goals and explore potential partnership opportunities.